ReviewJournal of pharmacy & bioallied sciences2024
Three-Dimensional Bioprinting as a Tool for Tissue Engineering: A Review.
Review in Journal of pharmacy & bioallied sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The field of reconstructive and regenerative therapy has shown an increased amount of interest in three-dimensional (3D) bioprinting techniques in recent years. This technique applies 3D printing methods to tissue engineering, utilizing additive manufacturing techniques and bio-inks containing biomaterials and living cells. 3D bioprinting has the potential to create the lost tissue precisely. It provides control over the bio-ink component and printing structure, enabling the creation of spatially diverse constructs for the treatment, regeneration, and restoration of various maxillofacial abnormalities, and appears to be a promising alternative. As a result, this review aims to discuss the advancements in 3D bioprinting, including its multiple applications in regenerative and reconstructive dentistry, as well as future perspectives, such as the evolution of 4D bioprinting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.